Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Mucosis
Mucosis
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Wellcome Trust grants Mucosis €3.7m for clinical trials in partnership with Imperial College
To progress SynGEM intranasal respiratory syncytial virus (RSV) vaccine
Research & Development
Mucosis enter partnership with Changchun BCHT Biotechnology of China
Raises €5m in new financing round
Pharmaceutical
Mucosis promotes Thomas Johnston to ceo
He joined the Dutch vaccine developer from Novavax in 2011
Research & Development
Partners win €1m Eurostars grant
ExpreS<sup>2</sup>ion, Mucosis and Copenhagen University to develop placental malaria vaccine
Subscribe now